ALLOPURINOL IN TREATMENT OF GOUT

被引：0
|
作者：
SEEBACH, LM
机构：
来源：
JOURNAL-LANCET | 1967年 / 87卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：411 / +
页数：1
相关论文
共 50 条
  • [41] INDIVIDUALISING ALLOPURINOL THERAPY IN GOUT
    Kannangara, D.
    Datta, I
    Indraratna, P.
    Stocker, S.
    Portek, I
    Graham, G.
    Williams, K.
    Day, R.
    INTERNAL MEDICINE JOURNAL, 2011, 41 : 30 - 30
  • [42] My gout and allopurinol desensitization
    Hoffman, LA
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2002, 8 (06) : 354 - 356
  • [43] WITHDRAWAL OF ALLOPURINOL IN PATIENTS WITH GOUT
    LOEBL, WY
    SCOTT, JT
    ANNALS OF THE RHEUMATIC DISEASES, 1974, 33 (04) : 304 - 307
  • [44] Cardiovascular Outcomes of Treatment with Febuxostat and Allopurinol in Gout Patients with Kidney Disease
    White, William B.
    Gunawardhana, Lhanoo
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [45] TREATMENT OF GOUT - ALLOPURINOL THERAPY IN 100 PATIENTS DURING 8 YEARS
    RIVELIS, L
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1975, 4 : 156 - 156
  • [46] Allopurinol Treatment for Gout: How Long to Reach Serum Urate Goal?
    Lim, Jean J.
    Fu, An-Chen
    Giordano, Jami
    Reasner, David S.
    Taylor, Douglas C. A.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [47] AZAPROPAZONE OR ALLOPURINOL IN THE TREATMENT OF CHRONIC GOUT AND/OR HYPERURICEMIA - A PRELIMINARY-REPORT
    TEMPLETON, JS
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1982, 36 (10): : 353 - 358
  • [48] COMPARISON OF COST OF ALLOPURINOL VS FEBUXOSTAT AS A FIRST LINE TREATMENT FOR GOUT
    Jutkowitz, E.
    Pizzi, L.
    Meltzer, M.
    VALUE IN HEALTH, 2010, 13 (03) : A123 - A123
  • [49] FACTORS ASSOCIATED WITH ALLOPURINOL ADHERENCE AND TREATMENT OUTCOME AMONG GOUT PATIENTS
    Asaiphanit, S.
    Narongroeknawin, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1049 - 1049
  • [50] Febuxostat or Allopurinol in Patients with Gout Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES)
    Alten, R.
    Mischkewitz, M.
    Nitschmann, S.
    INTERNIST, 2020, 61 (05): : 530 - 532
12345